Combination therapy in liver transplant recipients with hepatitis B virus without hepatitis B immune globulin

Digestive Diseases and Sciences

Volumn 52, Issue 10, 2007, Pages 2497-2500

  Neff, Guy W ^a,b   Kemmer, Nyingi ^a   Kaiser, Tiffany E ^a   Zacharias, Victoria C ^a   Alonzo, Michele ^a   Thomas, Mark ^b   Buell, Joseph ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

Author keywords

Adefovir; Hepatitis B immunoglobulin; Hepatitis B virus; Lamivudine; Liver transplantation

Indexed keywords

ADEFOVIR DIPIVOXIL; AMINOTRANSFERASE; ANTIVIRUS AGENT; DNA; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; METHYLPREDNISOLONE; TACROLIMUS;

ADULT; AGED; CLINICAL ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG COST; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION PROCESSING; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; PATIENT COMPLIANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; RECIPIENT; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; SEROLOGY; UNSPECIFIED SIDE EFFECT;

ADENINE; ADULT; AGED; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PHOSPHONIC ACIDS; RECURRENCE; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME;

EID: 34548495782     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-006-9658-3     Document Type: Review

References (25)

1. Ben-Ari Z, Mor E, Tur-Kaspa R (2003) Experience with lamivudine therapy for hepatitis B virus infection before and after liver transplantation, and review of the literature. J Intern Med 253:544-552
2. Fagiuali S, Mirante VG, Pompili M, et al. (2002) Liver transplantation: the Italian experience [comment]. Dig Liver Dis 34:640-648
3. Nery JR, Nery-Avila C, Reddy KR, et al. (2003) Use of liver grafts from donors positive for antihepatitis B-core antibody (anti-HBc) in the era of prophylaxis with hepatitis-B immunoglobulin and lamivudine. Transplantation 75:1179-1186
4. Lo CM, Fan ST, Liu CL, Lai CL, Wong J (2003) Prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Transplantation 75:S41-S44
5. Zheng S, Wu J, Wang W, Huang D, Liang T, Lu A (2002) Lamivudine as prophylaxis against hepatitis B virus reinfection following orthotopic liver transplantation. Chung-Hua i Hsueh Tsa Chih [Chinese Medical Journal] 82:445-448
6. Vargas HE, Dodson FS, Rakela J (2002) A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transplant 8:2-9
7. van Nunen AB, de Man RA, Heijtink RA, Vossen AC, Schalm SW (2002) Passive immunization of chronic hepatitis B patients on lamivudine therapy: A feasible issue? J Viral Hepatitis 9:221-228
8. Muller R, Gubernatis G, Farle M, et al. (1991) Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. J Hepatol 13:90-96
9. McGory RW, Ishitani MB, Oliveira WM, et al. (1996) Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 61:1358-1364
10. Markowitz JS, Martin P, Conrad AJ, et al. (1998) Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 28:585-589
11. McGory R (2000) Pharmacoeconomic analysis of HBV liver transplant therapies. Clin Transplant 14 (Suppl 2):29-38
12. Villamil FG (2002) Hepatitis B: progress in the last 15 years. Liver Transplant 8:S59-S66
13. Villamil FG, Vierling JM (1995) Recurrence of viral hepatitis after liver transplantation: insights into management. Liver Transplant Surg 1:89-99
14. Wang ZF, Zhu ZJ, Shen ZY (2005) Advances in prophylaxis and treatment of recurrent hepatitis B after liver transplantation. Hepatobil Pancreat Dis Int 4:509-514
15. Dodson SF, de Vera ME, Bonham CA, Geller DA, Rakela J, Fung JJ (2000) Lamivudine after hepatitis B immune globulin is effective in preventing hepatitis B recurrence after liver transplantation. Liver Transplantation 6:434-439
16. Kruger M (2000) European hepatitis B immunoglobulin trials: prevention of recurrent hepatitis B after liver transplantation. Clin Transplant 14 (Suppl 2):14-19
17. Perrillo RP, Kruger M, Sievers T, Lake JR (2000) Posttransplantation: emerging and future therapies. Semin Liver Dis 20 (Suppl 1):13-17
18. Seehofer D, Rayes N, Steinmuller T, et al. (2002) Combination prophylaxis with Hepatitis B immunoglobulin and lamivudine after liver transplantation minimizes HBV recurrence rates unless evolution of pretransplant lamivudine resistance. Z Gastroenterol 40:795-799
19. Lok AS (2002) Prevention of recurrent hepatitis B post-liver transplantation. Liver Transplant 8:S67-S73
20. Castells L, Vargas V, Rodriguez F, et al. (2002) Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation. Liver Transplant 8:892-900
21. Nery JR, Weppler D, Lavandera R, et al. (1999) Developing strategies for prevention and treatment of recurrent HBV in liver transplantation. Transplant Proc 31:485-486
22. Mutimer D (2006) Review article: hepatitis B and liver transplantation. Aliment Pharmacol Ther 23:1031-1041
23. Westland CE, Yang H, Delaney WE, et al. (2005) Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients. J Viral Hepat 12:67-73
24. Ben-Ari Z, Mor E, Manhaim V, et al. (2001) Passive immunization with OMRI-Hep-B for prevention of hepatitis B virus reinfection after liver transplantation. Transplant Proc 33:2895-2896
25. Farrell GC, Teoh NC (2006) Management of chronic hepatitis B virus infection: a new era of disease control. Intern Med J 36:100-113